Company intelligence / Profile preview

Jiangsu Guomai Medical Technology

Ownership: Private
Development stage: Commercial

Overview

Jiangsu Guomai Medical Technology is an active Chinese medical device/technology company. In late 2023 and early 2024, it became the subject of a significant equity investment/acquisition process by Meihua International Medical Technologies Co., Ltd. and Jiangsu Huadong Medical Device Industrial Co., Ltd., who are acquiring a combined 40% stake for approximately CNY 9.2 million (~$9.03 million USD). The deal is expected to close by December 18–19, 2024. No specific clinical results or product pipeline details are disclosed.

Modalities: Medical devicesDevice-based modalities
Industry: Therapeutic Medical Devices

Partnerships

Meihua International Medical Technologies Co., Ltd.Jiangsu Huadong Medical Device Industrial Co., Ltd.

Beyond the preview

Go deeper on Jiangsu Guomai Medical Technology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Jiangsu Guomai Medical Technology.

Explore the full profile